Has Andrew Queler, MD received payments from drug or device companies?

Yes. Drug and device makers reported $349 in general payments to Andrew Queler, MD across 19 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Queler, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Queler, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Queler, MD

Hospitalist · Hattiesburg, MSNPI 1336257690

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by AbbVie at 45.8% of the total. Reporting peaked in 2024 at $86 and has fallen 56.4% since, to $38 in 2025. That places this record below the midpoint for hospitalist clinicians in MS, where the typical reported total is $523.

$349in general payments, 2019–2025

Across 19 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$160
E.r. Squibb & Sons, L.L.C.$57
Boehringer Ingelheim$39
Pfizer$38
Gilead$36
Johnson & Johnson$20

What the payments were for

Food & beverage$349100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	8	$160
E.r. Squibb & Sons, L.L.C.	4	$57
Boehringer Ingelheim	2	$39
Pfizer	2	$38
Gilead	2	$36
Johnson & Johnson	1	$20

How this compares

$349 in reported general payments places this provider in the 40th percentile of 102 hospitalist providers in Mississippi.

See all hospitalist providers in Mississippi →

Medicare billing

Part B allowed, 2024

$81,590

Medicare patients

173

Services billed

948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	16	$9,303
Hydralazine Hcl	92	$1,037
Pantoprazole Sodium	67	$572
Carvedilol	94	$410
Minoxidil	40	$389
Amiodarone Hcl	23	$234
Metoprolol Succinate	26	$177
Doxycycline Monohydrate	27	$176
Isosorbide Mononitrate ErIsosorbide Mononitrate	15	$161
Levetiracetam	23	$158
Prednisone	29	$129
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	21	$121
ClopidogrelClopidogrel Bisulfate	17	$116
Metoprolol Tartrate	18	$106
Gabapentin	17	$68

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$38	$9,30316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 102 hospitalist providers in Mississippi.

Other hospitalist in Hattiesburg

Cherie PapizanHattiesburg$2K
Volkan OzduranHattiesburg$2K
Rami JabbourHattiesburg$2K
Sriharsha AthotaHattiesburg$2K
Roland EstarisHattiesburg$1K
Subodh AdhikariHattiesburg$1K
Mohammad AnindoHattiesburg$1K
Paul DrambareanHattiesburg$1K
Abdul MinhasHattiesburg$1K
Gregg AnaziaHattiesburg$1K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →